Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion type Assertion NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_head.
- NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion description "[Recently, clinical importance of determining KRAS mutations has been demonstrated in colorectal tumors as tumors harboring mutated KRAS genes were not responsive to therapy with EGFR-targeted antibodies such as cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_provenance.
- NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion evidence source_evidence_literature NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_provenance.
- NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion SIO_000772 21741959 NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_provenance.
- NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion wasDerivedFrom befree-2016 NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_provenance.
- NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_assertion wasGeneratedBy ECO_0000203 NP908371.RARtpdShn6GeRj-YzBzSRl10Li9Sp9-TsDu8Nb2hTl8RA130_provenance.